Selling And Administration Expenses Endring Dato
Acorda Therapeutics USD 21.82M 689K 2023-06
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
Baxter International USD 832M 47M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Heron Therapeutics USD 24.6M 11.84M 2023-09
Insmed USD 89.53M 1.1M 2023-12
Intrexon USD 9.2M 120K 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Merck USD 2.75B 272M 2023-12
Pacira USD 65.8M 2.15M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
Veracyte USD 49.06M 9.55M 2023-12



Ligand Pharmaceuticals Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.